Subscribe-to-CVN-Blog-Graphic-small.png

Defense Completes Openings in Accutane Trial

Posted by msch on Jan 13, 2010 4:49:00 PM

Accutane Trial Defense Opening Statement by Andrew See on behalf of Roche

Defense attorney Andrew See, from the Kansas City office of Shook, Hardy & Bacon, completed his opening statement on behalf of pharmaceutical defendant Hoffman-LaRoche (Roche) this afternoon as the McCarrell Accutane trial continued.

See hammered hard and repeatedly on his theme that although Andy McCarrell may have suffered mightily from Crohn's Disease, this Inflammatory Bowel Disease (IBD) was not caused by Accutane.

See said that the evidence would show McCarrell took Accutane briefly in 1995, and that McCarrell showed no symptoms of IBD until long after any remnant of Accutane had left his body. Instead, McCarrell's IBD appeared a year later, approximately two weeks after McCarrell began a double-antibiotics treatment regime.

Opening statements are now complete.  The McCarrell v. Hoffman-LaRoche Accutane trial will continue on Thursday at 9:30am Eastern.  CVN is webcasting the trial live, gavel-to-gavel. 

CVN is also offering free clips of both the plaintiff and defense opening statements.  As you can see in the images below, CVN also streams the digital evidence as it is presented to the jury.

Accutane Trial summary of defense opening statement.

 

Accutane trial's IBD timeline in the Roche opening statement

 

Accutane Trial diagram showing rate at which Accutane and its metabolites leave the body.

 

 

 

Topics: Toxic Torts, Products Liability, accutane, Pharmaceutical, McCarrell v. Hoffman-La Roche